BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 22388996)

  • 21. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study.
    Pease CT; Haugeberg G; Montague B; Hensor EM; Bhakta BB; Thomson W; Ollier WE; Morgan AW
    Rheumatology (Oxford); 2009 Feb; 48(2):123-7. PubMed ID: 18980958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polymyalgia rheumatica: What is the current status?].
    Seitz M
    Z Rheumatol; 2015 Aug; 74(6):507-10. PubMed ID: 26169748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.
    Nothnagl T; Leeb BF
    Drugs Aging; 2006; 23(5):391-402. PubMed ID: 16823992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of criteria for polymyalgia rheumatica.
    Bird HA; Esselinckx W; Dixon AS; Mowat AG; Wood PH
    Ann Rheum Dis; 1979 Oct; 38(5):434-9. PubMed ID: 518143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica.
    Kermani TA; Warrington KJ
    Ther Adv Musculoskelet Dis; 2014 Feb; 6(1):8-19. PubMed ID: 24489611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey.
    Dasgupta B; Salvarani C; Schirmer M; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL;
    J Rheumatol; 2008 Feb; 35(2):270-7. PubMed ID: 18050370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral musculoskeletal manifestations in polymyalgia rheumatica.
    Ceccato F; Roverano SG; Papasidero S; Barrionuevo A; Rillo OL; Paira SO
    J Clin Rheumatol; 2006 Aug; 12(4):167-71. PubMed ID: 16891918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical course of polymyalgia rheumatica in Chinese.
    Li WL; Lo Y; Leung MH; Wong WS; Mok MY
    Clin Rheumatol; 2010 Feb; 29(2):199-203. PubMed ID: 19915991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study.
    Prior JA; Muller S; Helliwell T; Hider SL; Barraclough K; Dasgupta B; Mallen CD
    Prim Health Care Res Dev; 2019 May; 20():e46. PubMed ID: 32799976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study.
    Santoro L; Birra D; Bosello S; Nesci A; Di Giorgio A; Peluso G; Giupponi B; Zaccone V; Gasbarrini A; Zoli A; Santoliquido A
    Scand J Rheumatol; 2020 Jan; 49(1):68-74. PubMed ID: 31418315
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants.
    Colaci M; Dichiara J; Aprile ML; Ippolito M; Schinocca C; Guggino G; Malatino L
    Front Med (Lausanne); 2022; 9():1042620. PubMed ID: 36465900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature.
    Calabrese C; Cappelli LC; Kostine M; Kirchner E; Braaten T; Calabrese L
    RMD Open; 2019; 5(1):e000906. PubMed ID: 31168414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
    Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Matteson EL; Dasgupta B
    Ann Rheum Dis; 2015 Oct; 74(10):1808-17. PubMed ID: 26359489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Abril A; Bachta A; Balint P; Barraclough K; Bianconi L; Buttgereit F; Carsons S; Ching D; Cid M; Cimmino M; Diamantopoulos A; Docken W; Duftner C; Fashanu B; Gilbert K; Hildreth P; Hollywood J; Jayne D; Lima M; Maharaj A; Mallen C; Martinez-Taboada V; Maz M; Merry S; Miller J; Mori S; Neill L; Nordborg E; Nott J; Padbury H; Pease C; Salvarani C; Schirmer M; Schmidt W; Spiera R; Tronnier D; Wagner A; Whitlock M; Matteson EL; Dasgupta B; ;
    Arthritis Rheumatol; 2015 Oct; 67(10):2569-80. PubMed ID: 26352874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus.
    Dejaco C; Duftner C; Cimmino MA; Dasgupta B; Salvarani C; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL; Schirmer M;
    Ann Rheum Dis; 2011 Mar; 70(3):447-53. PubMed ID: 21097803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyalgia rheumatica: clinical picture and principles of treatment.
    Zimmermann-Górska I
    Pol Arch Med Wewn; 2008 Jun; 118(6):377-80. PubMed ID: 18619195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.
    Helliwell T; Brouwer E; Pease CT; Hughes R; Hill CL; Neill LM; Halls S; Simon LS; Mallen CD; Boers M; Kirwan JR; Mackie SL
    J Rheumatol; 2016 Jan; 43(1):182-6. PubMed ID: 26568595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of polymyalgia rheumatica in a cohort of patients with idiopathic inflammatory myopathy.
    Douglass-Molloy H; Limaye V
    Clin Rheumatol; 2020 Apr; 39(4):1217-1221. PubMed ID: 31919772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.